|
PIGM expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.883900E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.235600E-02 |
| Normal-vs-Stage2 |
3.330100E-02 |
| Normal-vs-Stage3 |
8.208100E-04 |
| Normal-vs-Stage4 |
3.378500E-03 |
| Stage1-vs-Stage2 |
6.745800E-01 |
| Stage1-vs-Stage3 |
1.346630E-01 |
| Stage1-vs-Stage4 |
1.969440E-01 |
| Stage2-vs-Stage3 |
5.146000E-01 |
| Stage2-vs-Stage4 |
4.896200E-01 |
| Stage3-vs-Stage4 |
8.548600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.777400E-03 |
| Normal-vs-AfricanAmerican |
1.188840E-01 |
| Normal-vs-Asian |
4.819700E-02 |
| Caucasian-vs-AfricanAmerican |
8.068400E-01 |
| Caucasian-vs-Asian |
7.501400E-01 |
| AfricanAmerican-vs-Asian |
9.935000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.161360E-03 |
| Normal-vs-Female |
1.082260E-02 |
| Male-vs-Female |
1.429190E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.786300E-02 |
| Normal-vs-Age(41-60Yrs) |
3.919900E-03 |
| Normal-vs-Age(61-80Yrs) |
6.381200E-03 |
| Normal-vs-Age(81-100Yrs) |
1.480770E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.198000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.261400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.922000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.927000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.802000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.211800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.032200E-02 |
| Classical-VS-Follicular |
2.278100E-03 |
| Classical-VS-Other |
8.872000E-02 |
| Classical-VS-Normal |
7.637500E-02 |
| Tall-VS-Follicular |
8.794600E-01 |
| Tall-VS-Other |
4.933000E-01 |
| Tall-VS-Normal |
2.037900E-03 |
| Follicular-VS-Other |
5.091000E-01 |
| Follicular-VS-Normal |
4.195600E-04 |
| Other-VS-Normal |
2.430300E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.158300E-03 |
| Normal-vs-N1 |
8.442800E-04 |
| N0-vs-N1 |
1.620040E-01 |
|
|
